文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多囊卵巢综合征患者的粪便微生物群移植可诱导无菌小鼠发生代谢紊乱和卵巢功能障碍。

Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free mice.

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, 100730, China.

Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

出版信息

BMC Microbiol. 2024 Sep 28;24(1):364. doi: 10.1186/s12866-024-03513-z.


DOI:10.1186/s12866-024-03513-z
PMID:39333864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11437718/
Abstract

BACKGROUND: Dysbiosis of the microbiome is a key hallmark of polycystic ovary syndrome (PCOS). However, the interaction between the host and microbiome and its relevance to the pathogenesis of PCOS remain unclear. METHODS: To evaluate the role of the commensal gut microbiome in PCOS, we gavaged germ-free mice with the fecal microbiota from patients with PCOS or healthy individuals and evaluated the reproductive endocrine features of the recipient mice. RESULTS: Mice transplanted with fecal microbiota from PCOS patients and those transplanted from healthy controls presented different bacterial profiles and reproductive endocrine features. The fecal microbiota of the mice in the PCOS group was enriched in Phocaeicola, Mediterraneibacter, Oscillospiraceae, Lawsonibacter and Rikenellaceae. Fecal microbiota transplantation (FMT) from PCOS patients induced increased disruption of ovarian functions, lipo-metabolic disturbance, insulin resistance and an obese-like phenotype in recipient mice. CONCLUSION: Our findings suggest that the microbiome may govern the set point of PCOS-bearing individuals and that gut ecosystem manipulation may be a useful marker and target for the management of PCOS.

摘要

背景:微生物组的失调是多囊卵巢综合征(PCOS)的一个关键标志。然而,宿主与微生物组之间的相互作用及其与 PCOS 发病机制的相关性尚不清楚。

方法:为了评估共生肠道微生物组在 PCOS 中的作用,我们将 PCOS 患者和健康个体的粪便微生物群移植到无菌小鼠中,并评估受体小鼠的生殖内分泌特征。

结果:移植来自 PCOS 患者粪便微生物群的小鼠和移植来自健康对照的小鼠表现出不同的细菌谱和生殖内分泌特征。PCOS 组的粪便微生物群富含 Phocaeicola、Mediterraneibacter、Oscillospiraceae、Lawsonibacter 和 Rikenellaceae。来自 PCOS 患者的粪便微生物群移植(FMT)可导致受体小鼠卵巢功能破坏、脂代谢紊乱、胰岛素抵抗和肥胖样表型增加。

结论:我们的研究结果表明,微生物组可能控制 PCOS 患者的设定点,肠道生态系统的操纵可能是 PCOS 管理的有用标志物和靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/1aeaed56b809/12866_2024_3513_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/97f50b8d1d67/12866_2024_3513_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/982fd1e75790/12866_2024_3513_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/63eb0d52c30a/12866_2024_3513_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/ef4a3687c620/12866_2024_3513_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/973d85250d65/12866_2024_3513_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/1aeaed56b809/12866_2024_3513_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/97f50b8d1d67/12866_2024_3513_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/982fd1e75790/12866_2024_3513_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/63eb0d52c30a/12866_2024_3513_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/ef4a3687c620/12866_2024_3513_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/973d85250d65/12866_2024_3513_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11437718/1aeaed56b809/12866_2024_3513_Fig6_HTML.jpg

相似文献

[1]
Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free mice.

BMC Microbiol. 2024-9-28

[2]
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.

J Ovarian Res. 2023-7-14

[3]
Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome.

Microbiol Spectr. 2024-8-6

[4]
Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.

Front Cell Infect Microbiol. 2024

[5]
Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.

BMC Microbiol. 2024-5-17

[6]
A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.

J Am Coll Nutr. 2020

[7]
Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.

J Endocrinol Invest. 2021-8

[8]
Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.

Front Endocrinol (Lausanne). 2023

[9]
Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.

Microbiome. 2021-5-6

[10]
Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers.

Front Biosci (Landmark Ed). 2024-5-30

引用本文的文献

[1]
Gut Microbiota-Derived Acetate Ameliorates Endometriosis via JAK1/STAT3-Mediated M1 Macrophage Polarisation.

Microb Biotechnol. 2025-8

[2]
Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome and Its Association with Metabolic Abnormalities: A Review.

Int J Womens Health. 2025-7-18

[3]
The Role of the Gut Microbiota in Female Reproductive and Gynecological Health: Insights into Endometrial Signaling Pathways.

Life (Basel). 2025-5-9

本文引用的文献

[1]
Dysbiosis of the oral-gut microbiome in PCOS patients and its implication for noninvasive diagnosis.

Clin Transl Med. 2024-8

[2]
ggpicrust2: an R package for PICRUSt2 predicted functional profile analysis and visualization.

Bioinformatics. 2023-8-1

[3]
Greengenes2 unifies microbial data in a single reference tree.

Nat Biotechnol. 2024-5

[4]
Microbiota from young mice counteracts selective age-associated behavioral deficits.

Nat Aging. 2021-8

[5]
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals.

J Ovarian Res. 2022-10-28

[6]
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes.

Nat Commun. 2022-10-26

[7]
The interplay between PCOS pathology and diet on gut microbiota in a mouse model.

Gut Microbes. 2022

[8]
Multivariable association discovery in population-scale meta-omics studies.

PLoS Comput Biol. 2021-11

[9]
Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?

Cell Metab. 2021-6-1

[10]
Gut and vaginal microbiomes on steroids: implications for women's health.

Trends Endocrinol Metab. 2021-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索